Sharing Healthcare Wishes in Primary Care (SHARE) for Cognitive Impairment

Medstar CSA Collington, Mitchellville, MD
Sharing Healthcare Wishes in Primary Care (SHARE) +1 moreN/AWaitlist AvailableLed by Jennifer Wolff, PhDResearch Sponsored by Johns Hopkins University

Study Summary

This trial is testing whether the SHARE protocol leads to better communication and advance care planning among primary care patients with cognitive impairment and their family caregivers, compared to a control group receiving minimally enhanced usual care. SHARE includes two in-person meetings and three phone calls between the patient and caregiver and a primary care clinician.

Eligible Conditions
  • Cognitive Impairment

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow ups ~ 2-3 months after patient death
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2-3 months after patient death for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Between-Group Differences in Family-Reported Quality of Communication at 6-Months
Secondary outcome measures
Between-Group Differences in Bereaved Family Symptoms of Anxiety
Between-Group Differences in Bereaved Family-Reported Decisional Conflict
Between-Group Differences in Bereaved Family-Reported Decisional Regret
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: SHAREExperimental Treatment1 Intervention
SHARE components include: 1) a letter from the practice introducing the initiative, 2) access to a designated person (medical assistant, social worker, nurse, or lay person) trained to lead advance care planning discussions, 3) person-family agenda-setting to align perspectives about the role of the caregiver and stimulate discussion about goals of care, and 4) education about communication and available resources, including a 44-page brochure developed by the National Institute on Aging entitled "A Guide for Older People: Talking with your Doctor", a blank easy to complete advance directive, and facilitated registration to the patient portal (for patient and caregiver participants) to extend electronic interactions and information access to family.
Group II: Minimally Enhanced Usual CarePlacebo Group1 Intervention
Minimally enhanced usual care participants are provided with print educational materials that include a 44-page brochure developed by the National Institute on Aging entitled "A Guide for Older People: Talking with your Doctor" and a blank easy-to-complete advance directive.

Find a site

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,149 Previous Clinical Trials
14,809,083 Total Patients Enrolled
MedStar HealthOTHER
4 Previous Clinical Trials
70,168 Total Patients Enrolled
Johns Hopkins Community PhysiciansOTHER
4 Previous Clinical Trials
66,676 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,530 Previous Clinical Trials
5,214,626 Total Patients Enrolled
Jennifer Wolff, PhDPrincipal Investigator
Johns Hopkins Bloomberg School of Public Health
1 Previous Clinical Trials
87,000 Total Patients Enrolled

Media Library

Sharing Healthcare Wishes in Primary Care (SHARE) Clinical Trial Eligibility Overview. Trial Name: NCT04593472 — N/A
Cognitive Impairment Research Study Groups: Minimally Enhanced Usual Care, SHARE
Cognitive Impairment Clinical Trial 2023: Sharing Healthcare Wishes in Primary Care (SHARE) Highlights & Side Effects. Trial Name: NCT04593472 — N/A
Sharing Healthcare Wishes in Primary Care (SHARE) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04593472 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available slots for participants in the current clinical experiment?

"According to information available on clinicaltrials.gov, this medical experiment has resumed recruitment of participants after it was first posted in October 21st 2020 and last edited on October 11th 2022."

Answered by AI

What is the current capacity of participants for this clinical trial?

"Affirmative. Clinicaltrials.gov details that this clinical trial is enlisting participants, beginning with its initial posting on October 21st 2020 and most recently revised on October 11th 2022. This trial needs 248 patients from 10 sites to participate in it."

Answered by AI

How many areas in North America are conducting this medical experiment?

"Currently, 10 different medical trial sites are actively looking for patients to participate in this study. Some of the locations include Olney, Baltimore and Nottingham among other cities. To reduce travel burdens associated with participation, it is recommended that participants choose a site close to their residence."

Answered by AI
Recent research and studies
~61 spots leftby Aug 2024